Monthly Archives: February 2020
The federal government requests an extension on MAiD
Jocelyn Downie argues that the federal government’s request for more time to amend medical assistance in dying legislation leaves Canadians to face enduring, intolerable, and irremediable suffering.
Developing the Canadian Drugs and Substances Strategy
Janet Jones challenges the idea that the 2018 Canadian Drugs and Substances Strategy public consultation will lead to innovative approaches to addressing addiction in Canada.
Media promotes baseless slippery slope claims
Stuart Chambers critiques the latest crop of slippery slope arguments against the expansion of eligibility for medical assistance in dying.
Ensuring the integrity of clinical research
Ramseyer Apau Bediako and Chris Kaposy urge research ethics boards to be more proactive in their research oversight responsibility.
Impact Ethics 